https://www.prnewswire.com/news-releases/european-commission-approves-csls-andembry-garadacimab-for-the-prevention-of-recurrent-attacks-of-hereditary-angioedema-hae-302375479.html
- Forums
- ASX - By Stock
- Andembry(garadacimab) approved in Europe
CSL
csl limited
Add to My Watchlist
0.22%
!
$271.70

https://www.prnewswire.com/news-releases/european-commission-appr...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$271.70 |
Change
0.590(0.22%) |
Mkt cap ! $131.5B |
Open | High | Low | Value | Volume |
$271.53 | $272.21 | $271.24 | $27.95M | 102.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24 | $271.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$271.70 | 25 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9 | 271.780 |
4 | 586 | 271.770 |
1 | 4 | 271.750 |
4 | 59 | 271.740 |
3 | 79 | 271.730 |
Price($) | Vol. | No. |
---|---|---|
271.790 | 8 | 3 |
271.800 | 32 | 3 |
271.810 | 36 | 2 |
271.820 | 37 | 3 |
271.830 | 19 | 2 |
Last trade - 11.11am 31/07/2025 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |